The FDA approved Inpefa (sotagliflozin) for broad heart failure treatment in late May 2023. The approval was based on results from the SCORED trial and the SOLOIST-WHF (Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post-Worsening Heart Failure) trial. Betram Pitt, M.D. Bertram Pitt, M.D., professor emeritus of the University of […]
A new scientific statement from the American Heart Association reviews strategies to improve shared decision-making in cardiovascular care Embargoed until 4 a.m. CT/5 a.m. ET Monday, August 14, 2023 DALLAS, Aug. 14, 2023 – A new American Heart Association scientific statement highlights evidence that supports shared decision-making, a term that describes the process of ensuring […]
Amarin Corporation plc announces that the Scottish Medicines Consortium (SMC) has accepted VAZKEPA (icosapent ethyl) for reimbursement with a Patient Access Scheme* for secondary prevention in patients treated with a stable dose of statins, low-density lipoprotein (LDL) cholesterol levels >1.04mmol/L and ≤2.60mmol/L, raised fasting triglycerides (≥1.7mmol/L) and with established cardiovascular disease (CVD) defined as a history of any […]
Introduction Cardiovascular diseases are the leading cause of death worldwide, with ischemic heart disease being the most common type.1 ST-segment elevation myocardial infarction (STEMI) is the most serious manifestation of ischemic heart disease. Based on the national registries of the European Society of Cardiology) countries, the incidence rate of STEMI in other European countries ranged […]
ANI | | Posted by Krishna Priya Pallavi, Pennsylvania Aug 14, 2023 01:06 PM IST Share Via Copy Link The study shows when sleep is restricted to five hours per night, cardiovascular health indicators like heart rate, blood pressure deteriorate through the week. It is a mistake to think that sleeping in on weekends will […]
A strong association exists between polycystic ovarian syndrome (PCOS) and cardiovascular risk factors, but women with PCOS 40‒60 years of age are not at greater risk of cardiovascular morbidity and mortality, suggest the results of a study presented at the recent ESHRE 2023. “Women with PCOS are at increased risk of developing adverse cardiometabolic outcomes […]
A recent study conducted by researchers at Yonsei University College of Medicine has found that cancer survivors who smoke are at a higher risk of developing cardiovascular disease. Smoking is already recognized as a leading cause of cardiovascular conditions like myocardial infarction and stroke. However, the specific impact of smoking on the risk of cardiovascular […]
A study conducted by researchers at Yonsei University College of Medicine has revealed that cancer survivors who smoke face a heightened risk of developing cardiovascular disease. A Yonsei University College of Medicine research team found that smoking can increase the risk of cardiovascular disease for cancer survivors that smoke. They are, from left, Professors Kim […]
The injection drugs Wegovy and Ozempic, renowned for their weight loss effects, may also reduce the risk of serious heart problems, a recent trial found. Credit: Carsten Snejbjerg/Bloomberg via Getty Images Advertisement <div class="article-block article-text" data-behavior="newsletter_promo dfp_article_rendering" data-dfp-adword="Advertisement" data-newsletterpromo_article-text=" Sign up for Scientific American’s free newsletters. ” data-newsletterpromo_article-image=”https://static.scientificamerican.com/sciam/cache/file/4641809D-B8F1-41A3-9E5A87C21ADB2FD8_source.png” data-newsletterpromo_article-button-text=”Sign Up” data-newsletterpromo_article-button-link=”https://www.scientificamerican.com/page/newsletter-sign-up/?origincode=2018_sciam_ArticlePromo_NewsletterSignUp” name=”articleBody” itemprop=”articleBody”> Trial results […]
